Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
paritaprevir and ritonavir
.
Show all posts
Showing posts with label
paritaprevir and ritonavir
.
Show all posts
Tuesday, May 2, 2017
AbbVie Receives U.S. FDA Approval of Once-Daily Viekira XR (dasabuvir, ombitasvir, paritaprevir and ritonavir) for the Treatment of Genotype 1 Chronic Hepatitis C
›
In continuation of my update on Dasabuvir , ombitasvir , paritaprevir and ritonavir AbbVie (NYSE: ABBV), a global biopharmaceut...
›
Home
View web version
